nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP11A1—uterine cancer	0.462	0.659	CbGaD
Aminoglutethimide—CYP19A1—uterine cancer	0.239	0.341	CbGaD
Aminoglutethimide—CYP2C19—Progesterone—uterine cancer	0.0434	0.256	CbGbCtD
Aminoglutethimide—CYP1A2—Progesterone—uterine cancer	0.04	0.236	CbGbCtD
Aminoglutethimide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0317	0.186	CbGbCtD
Aminoglutethimide—CYP3A4—Progesterone—uterine cancer	0.021	0.124	CbGbCtD
Aminoglutethimide—CYP11A1—corpus luteum—uterine cancer	0.0194	0.399	CbGeAlD
Aminoglutethimide—CYP1A2—Etoposide—uterine cancer	0.0179	0.106	CbGbCtD
Aminoglutethimide—CYP19A1—corpus luteum—uterine cancer	0.0126	0.259	CbGeAlD
Aminoglutethimide—CYP3A4—Etoposide—uterine cancer	0.00939	0.0553	CbGbCtD
Aminoglutethimide—CYP3A4—Doxorubicin—uterine cancer	0.0064	0.0377	CbGbCtD
Aminoglutethimide—CYP19A1—semen—uterine cancer	0.00592	0.121	CbGeAlD
Aminoglutethimide—CYP11A1—Pregnenolone biosynthesis—AKR1B1—uterine cancer	0.00457	0.106	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Pregnenolone biosynthesis—STAR—uterine cancer	0.00457	0.106	CbGpPWpGaD
Aminoglutethimide—Glutethimide—CYP11A1—uterine cancer	0.00298	1	CrCbGaD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00223	0.0518	CbGpPWpGaD
Aminoglutethimide—Hirsutism—Progesterone—uterine cancer	0.00203	0.0579	CcSEcCtD
Aminoglutethimide—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.0524	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0475	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00162	0.0375	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00162	0.0375	CbGpPWpGaD
Aminoglutethimide—CYP11A1—decidua—uterine cancer	0.00158	0.0325	CbGeAlD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00148	0.0343	CbGpPWpGaD
Aminoglutethimide—CYP11A1—female reproductive system—uterine cancer	0.00125	0.0256	CbGeAlD
Aminoglutethimide—CYP11A1—female gonad—uterine cancer	0.00113	0.0233	CbGeAlD
Aminoglutethimide—Hepatotoxicity—Dactinomycin—uterine cancer	0.00108	0.0308	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00107	0.0248	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00107	0.0248	CbGpPWpGaD
Aminoglutethimide—CYP19A1—endometrium—uterine cancer	0.000978	0.0201	CbGeAlD
Aminoglutethimide—CYP11A1—Endogenous sterols—CYP19A1—uterine cancer	0.000949	0.022	CbGpPWpGaD
Aminoglutethimide—CYP19A1—uterus—uterine cancer	0.000901	0.0185	CbGeAlD
Aminoglutethimide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000858	0.0245	CcSEcCtD
Aminoglutethimide—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000855	0.0198	CbGpPWpGaD
Aminoglutethimide—CYP19A1—female reproductive system—uterine cancer	0.00081	0.0166	CbGeAlD
Aminoglutethimide—Hepatotoxicity—Etoposide—uterine cancer	0.00078	0.0223	CcSEcCtD
Aminoglutethimide—CYP19A1—female gonad—uterine cancer	0.000737	0.0151	CbGeAlD
Aminoglutethimide—CYP11A1—lymph node—uterine cancer	0.000729	0.015	CbGeAlD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—STAR—uterine cancer	0.000711	0.0165	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.000711	0.0165	CbGpPWpGaD
Aminoglutethimide—CYP1A2—renal system—uterine cancer	0.000677	0.0139	CbGeAlD
Aminoglutethimide—Drowsiness—Progesterone—uterine cancer	0.000659	0.0188	CcSEcCtD
Aminoglutethimide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000648	0.015	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.00064	0.0149	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000637	0.0148	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Carboplatin—uterine cancer	0.000632	0.0181	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000604	0.014	CbGpPWpGaD
Aminoglutethimide—CYP2C19—vagina—uterine cancer	0.000601	0.0123	CbGeAlD
Aminoglutethimide—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000597	0.017	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000532	0.0123	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000499	0.0116	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Dactinomycin—uterine cancer	0.000496	0.0142	CcSEcCtD
Aminoglutethimide—CYP3A4—renal system—uterine cancer	0.00049	0.0101	CbGeAlD
Aminoglutethimide—Neutropenia—Dactinomycin—uterine cancer	0.000488	0.0139	CcSEcCtD
Aminoglutethimide—Anaemia—Progesterone—uterine cancer	0.000476	0.0136	CcSEcCtD
Aminoglutethimide—CYP19A1—lymph node—uterine cancer	0.000474	0.00972	CbGeAlD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000457	0.0106	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000441	0.0102	CbGpPWpGaD
Aminoglutethimide—Myalgia—Progesterone—uterine cancer	0.000438	0.0125	CcSEcCtD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000435	0.0101	CbGpPWpGaD
Aminoglutethimide—Agranulocytosis—Dactinomycin—uterine cancer	0.000435	0.0124	CcSEcCtD
Aminoglutethimide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000431	0.0123	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000425	0.00987	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Progesterone—uterine cancer	0.00041	0.0117	CcSEcCtD
Aminoglutethimide—Anorexia—Progesterone—uterine cancer	0.000401	0.0114	CcSEcCtD
Aminoglutethimide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000397	0.0113	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000397	0.00921	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000395	0.00917	CbGpPWpGaD
Aminoglutethimide—CYP3A4—female reproductive system—uterine cancer	0.000393	0.00806	CbGeAlD
Aminoglutethimide—Hypotension—Progesterone—uterine cancer	0.000393	0.0112	CcSEcCtD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000392	0.00909	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000383	0.0109	CcSEcCtD
Aminoglutethimide—Somnolence—Progesterone—uterine cancer	0.000374	0.0107	CcSEcCtD
Aminoglutethimide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000372	0.0106	CcSEcCtD
Aminoglutethimide—Decreased appetite—Progesterone—uterine cancer	0.000365	0.0104	CcSEcCtD
Aminoglutethimide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.0104	CcSEcCtD
Aminoglutethimide—Pancytopenia—Etoposide—uterine cancer	0.000359	0.0103	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000357	0.00829	CbGpPWpGaD
Aminoglutethimide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000356	0.0102	CcSEcCtD
Aminoglutethimide—Neutropenia—Etoposide—uterine cancer	0.000353	0.0101	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000347	0.00991	CcSEcCtD
Aminoglutethimide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.00967	CcSEcCtD
Aminoglutethimide—Anaemia—Dactinomycin—uterine cancer	0.000336	0.0096	CcSEcCtD
Aminoglutethimide—Urticaria—Progesterone—uterine cancer	0.000334	0.00953	CcSEcCtD
Aminoglutethimide—Body temperature increased—Progesterone—uterine cancer	0.000332	0.00949	CcSEcCtD
Aminoglutethimide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000331	0.00945	CcSEcCtD
Aminoglutethimide—Leukopenia—Dactinomycin—uterine cancer	0.000326	0.0093	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000322	0.00746	CbGpPWpGaD
Aminoglutethimide—Agranulocytosis—Etoposide—uterine cancer	0.000315	0.00898	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000312	0.00724	CbGpPWpGaD
Aminoglutethimide—Myalgia—Dactinomycin—uterine cancer	0.00031	0.00885	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Progesterone—uterine cancer	0.00031	0.00884	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000303	0.00703	CbGpPWpGaD
Aminoglutethimide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00864	CcSEcCtD
Aminoglutethimide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.00859	CcSEcCtD
Aminoglutethimide—Pruritus—Progesterone—uterine cancer	0.000297	0.00849	CcSEcCtD
Aminoglutethimide—Anorexia—Dactinomycin—uterine cancer	0.000283	0.00808	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000282	0.00653	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000281	0.00801	CcSEcCtD
Aminoglutethimide—Dizziness—Progesterone—uterine cancer	0.000278	0.00793	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—GPX3—uterine cancer	0.000274	0.00636	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000271	0.00773	CcSEcCtD
Aminoglutethimide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000269	0.00769	CcSEcCtD
Aminoglutethimide—Vomiting—Progesterone—uterine cancer	0.000267	0.00763	CcSEcCtD
Aminoglutethimide—Rash—Progesterone—uterine cancer	0.000265	0.00757	CcSEcCtD
Aminoglutethimide—Dermatitis—Progesterone—uterine cancer	0.000265	0.00756	CcSEcCtD
Aminoglutethimide—Headache—Progesterone—uterine cancer	0.000263	0.00752	CcSEcCtD
Aminoglutethimide—Decreased appetite—Dactinomycin—uterine cancer	0.000258	0.00737	CcSEcCtD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000252	0.00584	CbGpPWpGaD
Aminoglutethimide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000252	0.00719	CcSEcCtD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000251	0.00581	CbGpPWpGaD
Aminoglutethimide—Nausea—Progesterone—uterine cancer	0.00025	0.00713	CcSEcCtD
Aminoglutethimide—Anaemia—Etoposide—uterine cancer	0.000243	0.00695	CcSEcCtD
Aminoglutethimide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000242	0.00691	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.00024	0.00557	CbGpPWpGaD
Aminoglutethimide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00686	CcSEcCtD
Aminoglutethimide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00685	CcSEcCtD
Aminoglutethimide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000239	0.00681	CcSEcCtD
Aminoglutethimide—Leukopenia—Etoposide—uterine cancer	0.000236	0.00673	CcSEcCtD
Aminoglutethimide—Body temperature increased—Dactinomycin—uterine cancer	0.000235	0.0067	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000229	0.00531	CbGpPWpGaD
Aminoglutethimide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00646	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.000219	0.00508	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Dactinomycin—uterine cancer	0.000219	0.00625	CcSEcCtD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00021	0.00488	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Etoposide—uterine cancer	0.00021	0.00599	CcSEcCtD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.00021	0.00486	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.00021	0.00486	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000207	0.0048	CbGpPWpGaD
Aminoglutethimide—Anorexia—Etoposide—uterine cancer	0.000205	0.00585	CcSEcCtD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	0.000204	0.00474	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Epirubicin—uterine cancer	0.000201	0.00575	CcSEcCtD
Aminoglutethimide—Hypotension—Etoposide—uterine cancer	0.000201	0.00574	CcSEcCtD
Aminoglutethimide—Neutropenia—Epirubicin—uterine cancer	0.000198	0.00566	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000193	0.00447	CbGpPWpGaD
Aminoglutethimide—Somnolence—Etoposide—uterine cancer	0.000191	0.00546	CcSEcCtD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00019	0.00441	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP19A1—uterine cancer	0.00019	0.0044	CbGpPWpGaD
Aminoglutethimide—Drowsiness—Epirubicin—uterine cancer	0.000189	0.00539	CcSEcCtD
Aminoglutethimide—Vomiting—Dactinomycin—uterine cancer	0.000189	0.00539	CcSEcCtD
Aminoglutethimide—Rash—Dactinomycin—uterine cancer	0.000187	0.00535	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000187	0.00434	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Etoposide—uterine cancer	0.000187	0.00534	CcSEcCtD
Aminoglutethimide—Pancytopenia—Doxorubicin—uterine cancer	0.000186	0.00532	CcSEcCtD
Aminoglutethimide—Neutropenia—Doxorubicin—uterine cancer	0.000183	0.00523	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	0.000182	0.00421	CbGpPWpGaD
Aminoglutethimide—Nausea—Dactinomycin—uterine cancer	0.000176	0.00504	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Epirubicin—uterine cancer	0.000176	0.00503	CcSEcCtD
Aminoglutethimide—Drowsiness—Doxorubicin—uterine cancer	0.000175	0.00499	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	0.000171	0.00396	CbGpPWpGaD
Aminoglutethimide—Urticaria—Etoposide—uterine cancer	0.000171	0.00488	CcSEcCtD
Aminoglutethimide—Body temperature increased—Etoposide—uterine cancer	0.00017	0.00485	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000169	0.00391	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000166	0.00384	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000166	0.00384	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000164	0.0038	CbGpPWpGaD
Aminoglutethimide—Agranulocytosis—Doxorubicin—uterine cancer	0.000163	0.00466	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000159	0.00369	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Etoposide—uterine cancer	0.000158	0.00452	CcSEcCtD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000156	0.00362	CbGpPWpGaD
Aminoglutethimide—Pruritus—Etoposide—uterine cancer	0.000152	0.00434	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000152	0.00352	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00015	0.00348	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000148	0.00344	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	0.000147	0.00341	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.000146	0.00338	CbGpPWpGaD
Aminoglutethimide—Dizziness—Etoposide—uterine cancer	0.000142	0.00406	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000142	0.00329	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00014	0.00324	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	0.00014	0.00324	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	0.000137	0.00317	CbGpPWpGaD
Aminoglutethimide—Vomiting—Etoposide—uterine cancer	0.000137	0.0039	CcSEcCtD
Aminoglutethimide—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	0.000137	0.00317	CbGpPWpGaD
Aminoglutethimide—Anaemia—Epirubicin—uterine cancer	0.000136	0.0039	CcSEcCtD
Aminoglutethimide—Rash—Etoposide—uterine cancer	0.000136	0.00387	CcSEcCtD
Aminoglutethimide—Dermatitis—Etoposide—uterine cancer	0.000135	0.00387	CcSEcCtD
Aminoglutethimide—Headache—Etoposide—uterine cancer	0.000135	0.00385	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.000134	0.00312	CbGpPWpGaD
Aminoglutethimide—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	0.000133	0.00309	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Epirubicin—uterine cancer	0.000132	0.00377	CcSEcCtD
Aminoglutethimide—Nausea—Etoposide—uterine cancer	0.000128	0.00365	CcSEcCtD
Aminoglutethimide—Anaemia—Doxorubicin—uterine cancer	0.000126	0.00361	CcSEcCtD
Aminoglutethimide—Myalgia—Epirubicin—uterine cancer	0.000126	0.00359	CcSEcCtD
Aminoglutethimide—Leukopenia—Doxorubicin—uterine cancer	0.000122	0.00349	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000122	0.00282	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000122	0.00282	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Epirubicin—uterine cancer	0.000118	0.00336	CcSEcCtD
Aminoglutethimide—Myalgia—Doxorubicin—uterine cancer	0.000116	0.00332	CcSEcCtD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000116	0.00269	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000115	0.00266	CbGpPWpGaD
Aminoglutethimide—Anorexia—Epirubicin—uterine cancer	0.000115	0.00328	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000115	0.00266	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000114	0.00265	CbGpPWpGaD
Aminoglutethimide—Hypotension—Epirubicin—uterine cancer	0.000113	0.00321	CcSEcCtD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00011	0.00256	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00011	0.00313	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00011	0.00254	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00011	0.00254	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000109	0.00253	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Doxorubicin—uterine cancer	0.000109	0.00311	CcSEcCtD
Aminoglutethimide—Somnolence—Epirubicin—uterine cancer	0.000107	0.00306	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000107	0.00247	CbGpPWpGaD
Aminoglutethimide—Anorexia—Doxorubicin—uterine cancer	0.000106	0.00303	CcSEcCtD
Aminoglutethimide—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000105	0.00244	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Epirubicin—uterine cancer	0.000105	0.00299	CcSEcCtD
Aminoglutethimide—Hypotension—Doxorubicin—uterine cancer	0.000104	0.00297	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism—NDUFB11—uterine cancer	0.000102	0.00237	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—SRD5A2—uterine cancer	0.000102	0.00237	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000102	0.0029	CcSEcCtD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.0001	0.00233	CbGpPWpGaD
Aminoglutethimide—Somnolence—Doxorubicin—uterine cancer	9.91e-05	0.00283	CcSEcCtD
Aminoglutethimide—Decreased appetite—Doxorubicin—uterine cancer	9.69e-05	0.00277	CcSEcCtD
Aminoglutethimide—Urticaria—Epirubicin—uterine cancer	9.57e-05	0.00273	CcSEcCtD
Aminoglutethimide—Body temperature increased—Epirubicin—uterine cancer	9.53e-05	0.00272	CcSEcCtD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9.39e-05	0.00218	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.36e-05	0.00217	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	9.32e-05	0.00216	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	9.12e-05	0.00212	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.95e-05	0.00208	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Epirubicin—uterine cancer	8.88e-05	0.00253	CcSEcCtD
Aminoglutethimide—Urticaria—Doxorubicin—uterine cancer	8.86e-05	0.00253	CcSEcCtD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	8.84e-05	0.00205	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Doxorubicin—uterine cancer	8.81e-05	0.00252	CcSEcCtD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	8.81e-05	0.00204	CbGpPWpGaD
Aminoglutethimide—Pruritus—Epirubicin—uterine cancer	8.52e-05	0.00243	CcSEcCtD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.52e-05	0.00198	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.41e-05	0.00195	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	8.29e-05	0.00192	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	8.22e-05	0.00191	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Doxorubicin—uterine cancer	8.21e-05	0.00235	CcSEcCtD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	8.18e-05	0.0019	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	8.11e-05	0.00188	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.05e-05	0.00187	CbGpPWpGaD
Aminoglutethimide—Dizziness—Epirubicin—uterine cancer	7.97e-05	0.00228	CcSEcCtD
Aminoglutethimide—Pruritus—Doxorubicin—uterine cancer	7.89e-05	0.00225	CcSEcCtD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	7.82e-05	0.00181	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	7.72e-05	0.00179	CbGpPWpGaD
Aminoglutethimide—Vomiting—Epirubicin—uterine cancer	7.66e-05	0.00219	CcSEcCtD
Aminoglutethimide—Rash—Epirubicin—uterine cancer	7.6e-05	0.00217	CcSEcCtD
Aminoglutethimide—Dermatitis—Epirubicin—uterine cancer	7.59e-05	0.00217	CcSEcCtD
Aminoglutethimide—Headache—Epirubicin—uterine cancer	7.55e-05	0.00216	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—AKT1—uterine cancer	7.54e-05	0.00175	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—AKR1B1—uterine cancer	7.37e-05	0.00171	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—STAR—uterine cancer	7.37e-05	0.00171	CbGpPWpGaD
Aminoglutethimide—Dizziness—Doxorubicin—uterine cancer	7.37e-05	0.00211	CcSEcCtD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.36e-05	0.00171	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.29e-05	0.00169	CbGpPWpGaD
Aminoglutethimide—Nausea—Epirubicin—uterine cancer	7.16e-05	0.00204	CcSEcCtD
Aminoglutethimide—Vomiting—Doxorubicin—uterine cancer	7.09e-05	0.00202	CcSEcCtD
Aminoglutethimide—Rash—Doxorubicin—uterine cancer	7.03e-05	0.00201	CcSEcCtD
Aminoglutethimide—Dermatitis—Doxorubicin—uterine cancer	7.02e-05	0.00201	CcSEcCtD
Aminoglutethimide—Headache—Doxorubicin—uterine cancer	6.98e-05	0.00199	CcSEcCtD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.91e-05	0.0016	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	6.86e-05	0.00159	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NDUFB11—uterine cancer	6.76e-05	0.00157	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—SRD5A2—uterine cancer	6.76e-05	0.00157	CbGpPWpGaD
Aminoglutethimide—Nausea—Doxorubicin—uterine cancer	6.62e-05	0.00189	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.56e-05	0.00152	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	6.46e-05	0.0015	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	6.37e-05	0.00148	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	6.2e-05	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	6.2e-05	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.2e-05	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	6.1e-05	0.00142	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.03e-05	0.0014	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	6.02e-05	0.0014	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	6.02e-05	0.0014	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	5.98e-05	0.00139	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	5.83e-05	0.00135	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—POLD1—uterine cancer	5.79e-05	0.00134	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.74e-05	0.00133	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	5.56e-05	0.00129	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	5.44e-05	0.00126	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	5.44e-05	0.00126	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—AKR1C1—uterine cancer	5.41e-05	0.00126	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.32e-05	0.00123	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.32e-05	0.00123	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.3e-05	0.00123	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	5.27e-05	0.00122	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.16e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.09e-05	0.00118	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.99e-05	0.00116	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.92e-05	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—AKR1B1—uterine cancer	4.88e-05	0.00113	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—STAR—uterine cancer	4.88e-05	0.00113	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—RRM2—uterine cancer	4.82e-05	0.00112	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	4.75e-05	0.0011	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	4.69e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—DCN—uterine cancer	4.68e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.64e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	4.48e-05	0.00104	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.38e-05	0.00102	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—AKR1C3—uterine cancer	4.17e-05	0.000967	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.15e-05	0.000962	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.15e-05	0.000962	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	3.98e-05	0.000924	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.91e-05	0.000906	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—POLD1—uterine cancer	3.83e-05	0.000889	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.73e-05	0.000864	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.67e-05	0.000851	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.62e-05	0.00084	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—AKR1C1—uterine cancer	3.59e-05	0.000832	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	3.36e-05	0.00078	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.28e-05	0.000761	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.28e-05	0.000761	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP19A1—uterine cancer	3.25e-05	0.000753	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—STK11—uterine cancer	3.25e-05	0.000753	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—RRM2—uterine cancer	3.2e-05	0.000741	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.18e-05	0.000739	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—DCN—uterine cancer	3.1e-05	0.00072	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.05e-05	0.000707	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.04e-05	0.000706	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.01e-05	0.000698	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP11A1—uterine cancer	2.92e-05	0.000678	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.91e-05	0.000674	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—AKR1C3—uterine cancer	2.76e-05	0.00064	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.55e-05	0.000593	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.55e-05	0.000593	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.48e-05	0.000576	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—MTHFR—uterine cancer	2.44e-05	0.000566	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—STAR—uterine cancer	2.37e-05	0.00055	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.37e-05	0.00055	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.34e-05	0.000544	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.34e-05	0.000544	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—STK11—uterine cancer	2.15e-05	0.000499	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.15e-05	0.000499	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.02e-05	0.000468	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.97e-05	0.000457	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.97e-05	0.000457	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.92e-05	0.000447	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—POLD1—uterine cancer	1.86e-05	0.000432	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—STAR—uterine cancer	1.85e-05	0.000428	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.85e-05	0.000428	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.83e-05	0.000424	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.74e-05	0.000404	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—MTHFR—uterine cancer	1.62e-05	0.000375	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—RRM2—uterine cancer	1.55e-05	0.00036	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—DCN—uterine cancer	1.51e-05	0.000349	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—POLD1—uterine cancer	1.45e-05	0.000336	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—STAR—uterine cancer	1.43e-05	0.000331	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.43e-05	0.000331	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.42e-05	0.00033	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.42e-05	0.000329	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTEN—uterine cancer	1.36e-05	0.000315	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.36e-05	0.000314	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.34e-05	0.000311	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—EP300—uterine cancer	1.29e-05	0.0003	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—RRM2—uterine cancer	1.21e-05	0.00028	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—DCN—uterine cancer	1.17e-05	0.000272	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—POLD1—uterine cancer	1.12e-05	0.000259	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.11e-05	0.000256	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.05e-05	0.000243	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000242	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—STK11—uterine cancer	1.04e-05	0.000242	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.000242	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.79e-06	0.000227	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PIK3CA—uterine cancer	9.57e-06	0.000222	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.34e-06	0.000217	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—RRM2—uterine cancer	9.32e-06	0.000216	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—DCN—uterine cancer	9.05e-06	0.00021	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTEN—uterine cancer	8.99e-06	0.000209	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—EP300—uterine cancer	8.57e-06	0.000199	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.53e-06	0.000198	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—STK11—uterine cancer	8.13e-06	0.000189	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP19A1—uterine cancer	8.13e-06	0.000189	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.05e-06	0.000187	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—MTHFR—uterine cancer	7.84e-06	0.000182	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—AKT1—uterine cancer	7.82e-06	0.000181	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.63e-06	0.000177	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.28e-06	0.000169	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.91e-06	0.00016	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CA—uterine cancer	6.34e-06	0.000147	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.27e-06	0.000146	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—STK11—uterine cancer	6.27e-06	0.000146	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—MTHFR—uterine cancer	6.11e-06	0.000142	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.38e-06	0.000125	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—AKT1—uterine cancer	5.18e-06	0.00012	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MTHFR—uterine cancer	4.72e-06	0.000109	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTEN—uterine cancer	4.36e-06	0.000101	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—EP300—uterine cancer	4.16e-06	9.65e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTEN—uterine cancer	3.4e-06	7.89e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—EP300—uterine cancer	3.24e-06	7.52e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.08e-06	7.14e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTEN—uterine cancer	2.62e-06	6.09e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—AKT1—uterine cancer	2.51e-06	5.83e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—EP300—uterine cancer	2.5e-06	5.8e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.4e-06	5.56e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—AKT1—uterine cancer	1.96e-06	4.54e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.85e-06	4.29e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—AKT1—uterine cancer	1.51e-06	3.51e-05	CbGpPWpGaD
